Cannabis Companies Cater to an Increasingly Large and

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
314
Cannabis Companies Cater to an Increasingly Large and Diverse Industry

NetworkNewsWire Editorial Coverage: The predictions for the cannabis industry are staggering. Statista predicts the market may exceed $37.3 billion by 2024. Meanwhile, Forbes estimated the $6.5 billion market in 2016 could grow to $30 billion by 2021, and Bloomberg predicts an increase to $50 billion by 2026. The market is being fueled by demand and legalization, and it’s not just about plants. Equipment, infrastructure, cannabidiol products, and investors are components of an industry that seems to have unlimited growth potential. For example, PotNetwork Holding, Inc. (POTN) (POTN Profile) delivers, through its Diamond CBD subsidiary, widely-distributed CBD hemp extracts used in an assortment of edible gummies available in various types and flavors, vapor liquids, vaping pens, shot packages, and capsules. Others contributing to a rapidly diversifying industry include Agritek Holdings, Inc. (AGTK), Marijuana Company of America (MCOA), Hemp, Inc. (HEMP), and mCig, Inc. (MCIG).

PotNetwork Holding (POTN) is focused on multiple verticals within the cannabis industry, and, by sourcing hemp outside the U.S., side-steps current federally-based legal problems involved in growing cannabis domestically. Through this strategy, the company can deliver its products to every state as well as internationally. Among its list of 15 brands is Diamond CBD Gummies, CBD Liquid Gold, Premium Hemp Liquid Pet, Relax Extreme CBD, and CBD Double Shot.

As the CBD industry heats up, PotNetwork subsidiary Diamond CBD continues to see demand for its products. During its exhibit at the ASD Market Week Event in Las Vegas earlier this month, Diamond CBD generated more than $320,000 in revenues (http://nnw.fm/mv9aQ). While the event was a financial win for the company, it also provided considerable brand exposure to an attending audience of more than 40,000 buyers from 88 countries.

In the first two quarters of 2017, PotNetwork reported $5.0 million in sales for its Diamond CBD products, $3.2 million of which were generated in the second quarter alone, representing an increase of 1,495 percent over prior-year second-quarter revenues. This achievement puts the company on track to exceed its fiscal year 2017 forecasts (http://nnw.fm/KxqP2).

“We remain steadfast in our efforts to build real value in our Company. The level of acceptance we are experiencing can only be surpassed by our short and long-term vision for growth. As we continue to accelerate in sales performance, we embrace the opportunity to create a real and tangible success which we expect would ultimately be reflected in shareholder value,” PotNetwork CEO Gary Blum stated in the earnings release.

As PotNetwork grows its market reach, the company’s Diamond CBD subsidiary is also pursuing medical applications of CBD. Mounting research industry-wide demonstrates CBD’s potential to provide symptomatic relief for a wide range of ailments, including rheumatoid arthritis, diabetes, alcoholism, post-traumatic stress disorder (PTSD), epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, among many others. Recognizing considerable opportunity in this field, Diamond CBD is conducting its own research to develop premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives to potentially address these key markets.

To assist with this endeavor, PotNetwork is assembling an advisory board of physicians and medical cannabis specialists to support management’s plans to formulate, produce, and market a spectrum of exclusive and diversely targeted CBD blends. The first to join this new board is Dr. Mark G. Sabbota, who is board certified in internal medicine and cardiology. His experience includes a comprehensive understanding of cannabinoid attributes and corresponding knowledge based on research studies, along with Controlled Substance and DEA Licensure. He is joined by Dr. David M. Feldbaum, MD, FACS, who was named to the board earlier this month (http://nnw.fm/gq1QO). Certified in vascular surgery by the American Board of Surgery, Dr. Feldbaum brings to the table substantial knowledge of the intricacies of vascular health and an acquired understanding of how CBD components can contribute to the optimization of results in his area of expertise.

“This is an exciting time to be on the forefront of the CBD revolution. Being instrumental in the development of such cutting-edge developments, I believe we are enabled to make a difference in the quality of life for many. We stand at the threshold of great new discoveries,” Dr. Feldbaum stated in the press release announcing his appointment.

Dr. Feldbaum isn’t the only one who sees the potential of PotNetwork’s broader business model. In June, SeeThruEquity initiated coverage of PotNetwork with a price target of $0.25. Among other highlights, the analyst noted strength in Diamond CBD’s sales momentum and an aggressive marketing campaign. PotNetwork currently trades around $0.05 to $0.06. Among other key items, the analyst report (http://nnw.fm/fc27Ks) notes PotNetwork’s year-over-year Q1 2017 revenue growth of 178% and forecasts an increase of 712% in revenues to $8.3 million based on new product launches, strong marketing, and extended international market reach.

A look at other players in the diversified cannabis industry are further evidence of increasing demand, application and momentum.

Year-to-date, real estate investment firm and branding consultant Agritek Holdings (AGTK) has doubled the size of its brand portfolio to include four lines, and, earlier this month, it received an additional $300,000 in backing to fund the development of its land projects in Puerto Rico, Colorado, Canada and Washington State (http://nnw.fm/tR1Mc).

Agritek says it has started construction on a cultivation facility in Puerto Rico (http://nnw.fm/gAw0o), where it is funding a 25,000-square-foot facility near San Juan, along with the project’s equipment and extraction systems. Per an operations and licensing agreement, the company will be able to take advantage of multiple revenue streams, equipment lease back fees, and monthly consulting fees. It will also have exclusivity for the sale of its oils, vape products, and edibles, products used in Puerto Rico by people with anxiety, multiple sclerosis, epilepsy, and cancer among 14 preapproved conditions for which medical marijuana is permitted.

Agritek also recently announced that it is receiving orders for its MicroDose Oral Strips brand, an alternative to traditional cannabis products in that they are dissolved under the tongue or between the gum and cheek in the mouth, allowing the ingredients to be absorbed directly into the bloodstream.

Marijuana Company of America (MCOA) has seen growth in its cannabis-related operations as well, in the form of a $5 million fixed funding commitment in August and a $250,000 investment in MoneyTrac Technology, Inc. The deal gives the company a 15% ownership interest in the firm and opens the door to electronic payment processing services, such as the use of mobile applications, E-Wallet services, and processing of prepaid, debit, and credit cards. It also patented its herbal brain health product, hempSMART™ Brain, last month, which is intended to support neurological health and promote neurogenesis through its cannabidiol formulation.

Hemp, Inc. (HEMP) hasn’t slowed the pace either. In January, the company announced plans to expand its presence in North Carolina, with a 3,000-acre hemp farm, following agreements to purchase 1,000 acres from Mullen View Farms and 500 acres from John Finch Farms. The company also has a 70,000-square-foot industrial processing facility in Spring Hope, North Carolina. Aside from its growing operations, it also recently launched a critical piece of equipment. The NuAxon Tech CO2 Supercritical Extractor was purchased in a joint venture with Freedom Leaf, Inc. (OTCQB: FRLF). This system is expected to significantly boost revenue and facilitate growing, cultivation, and cloning processes for high cannabidiol plants.

Serving the cultivation, construction, and production packaging aspects of the marijuana industry, mCig, Inc. (MCIG) is no longer just a vaporizer manufacturer. It has also expanded into the merchant processing segment. The company offers secure payment solutions to participating dispensaries, at low rates for e-commerce and businesses that accept certain credit cards. With high uptime, fast-clearing funds, and secure transactions, the processing system is well-suited for businesses selling cannabidiol products via e-commerce websites. In addition, the company recently applauded the Senate for an amendment that would prevent the government from interfering with medical marijuana programs where they are legal. The legislation is a full amendment to the Commerce, Justice, and Science Appropriations Bill for 2018, prohibiting federal funds from being used to stop states from implementing laws regarding medical marijuana use, possession, distribution, and cultivation.

As discussed above, growth in the global cannabis industry is accelerating due to increased legislation, consumer demand, and the innovations of key market players. PotNetwork Holding is one example of the power of product diversity as it reaches across the industry in the U.S. and internationally. The company continues to execute its mission of making an impact on an industry that, while in its relative infancy, continues to surpass expectations and yield incredible opportunity for growth.

For more information on PotNetwork Holding please visit: PotNetwork Holding, Inc. (POTN)

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Potnetwork Holdings, Inc. (POTN) Stock Research Links

POTN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading